S&P 500 Beats a Small Retreat as Trade Deals Draw Investor Focus While Fed Punts
The S&P 500 (Index: SPX) retreated a half percent from its previous week’s close, ending the trading week at 5,659.91. During the week, there were two big stories driving stock prices: the Fed’s choice to not resume cutting U.S. interest rates until later in 2025 and the Trump administration’s progress in its trade negotiations after it imposed higher tariffs on U.S. trading partners last month.
The Fed’s reluctance to cut U.S. interest rates drew most investor focus in the early part of the week, which saw the index drop almost 1.5% through Tuesday as Fed officials were expected to punt on cutting rates. The market’s direction changed on Wednesday after the news broke that U.S. and Chinese trade negotiators would meet during the upcoming weekend in Switzerland.
That change in momentum continued on Thursday as the U.S. announced its first major trade deal with the United Kingdom and as more information about the pending trade negotiations with China came out. Friday saw the upward momentum stall with no real new information to affect investor outlook.
The latest update of the alternative futures chart puts the index’ trajectory in the middle of the redzone forecast range we modified in last week’s edition of the S&P 500 chaos series.
The stage is now set for next week, when whatever news comes out from Switzerland over the weekend will drive stock prices. Speaking of which, here is are the headlines that represent the random onset of new information investors had to absorb during the trading week ending on Friday, 9 May 2025.
- Monday, 5 May 2025
-
- Signs and portents for the U.S. economy:
- Oil ends at four-year lows as OPEC+ accelerates output hikes
- Trump orders 100% tariff on foreign-made movies to save ‘dying’ Hollywood
- Fed policymakers expected to keep rates steady as tariffs roil outlook
- Bigger trouble developing in China:
- JapanGov minions back off threat to dump US treasuries:
- BOJ minions think they have time to hike Japan’s interest rates:
- Nasdaq, S&P, and Dow ended lower ahead of the Fed’s rate decision
- Tuesday, 6 May 2025
-
- Signs and portents for the U.S. economy:
- The heart of the US oil boom is slowing
- Diamondback lowers output forecast, says US shale at tipping point
- Tariff-Frontrunning Sparks Record Trade Deficit in March
- Bigger trouble, stimulus developing in China:
- Thermal coal prices hit 4-year low in Asia as China imports wane
- Wall Street extends losses to a second straight day ahead of Fed rate decision
- Wednesday, 7 May 2025
-
- Signs and portents for the U.S. economy:
- Top officials from U.S. and China to hold trade talks on Saturday in Geneva
- Oil settles lower as hopes dim for US-China trade and supply worries ease
- Fed minions do what they were expected to do, despite rising risks to US economy:
- Fed likely to leave rates unchanged as it hunts for clarity on the economy
- Fed sees rising risks to economy as it leaves rates unchanged
- Bigger stimulus developing in China:
- China c.bank cuts 7-day reverse repo rate, effective May 8
- China injects ‘tactical’ monetary stimulus ahead of US trade meeting
- Central banks rethinking direction of their monetary policies:
- Major central banks’ easing push slows to a trickle in April
- Brazil central bank hikes rates to near 20-year high, leaves next steps open
- Bank of England set to cut rates amid worries about Trump tariff fallout
- BOJ split over how US policies impact rate hikes, March minutes show
- Eurozone minions threaten tariffs on U.S. goods:
- Wall Street closes out choppy trading session by snapping a two-day losing streak
- Thursday, 8 May 2025
-
- Signs and portents for the U.S. economy:
- Britain set to strike first deal to cut Trump tariffs
- Trump says China wants to make a trade deal, is open to lowering tariffs if talks go well
- Near-record US container import streak expected to snap in May due to tariffs
- Oil prices steady after dropping as economic uncertainty, supply concerns weigh
- OPEC April oil output edges lower despite plans for hike, survey finds
- U.S. exports of natural gas liquids touch record high in April
- Higher interest rates to delay U.S. residential market recovery, CRH CEO says
- Bigger trouble, stimulus developing in China:
- Trade war set to slash China’s steel exports, aggravating oversupply at home
- China exempts some US imports from tariffs
- BOE minions cut UK interest rates:
- Bigger trouble developing in Japan:
- ECB minions still excited to deliver more interest rate cuts to Eurozone:
- Wall Street ends higher after Trump says ‘go out and buy stock now’
- Friday, 9 May 2025
-
- Signs and portents for the U.S. economy:
- Ahead of key China talks, Trump says 80% tariff ‘seems right’
- Exclusive: India offers to slash tariff gap by two-thirds in dash to seal trade pact with Trump
- Fed minions say they don’t really know what’s going on while confidently asserting the US job market is doing great and that tariffs will slow the economy and cause inflation:
- Fed officials, citing uncertainty, reiterate patient policy stance
- Fed’s Kugler says US labor market stable, close to maximum employment
- Fed’s Barr: tariffs to boost inflation, slow growth later this year
- Fed’s independent structure has proved its worth, Waller says
- Ex Fed’s Warsh highlights a path to lower rates, takes a fresh dig at the Fed
- Bigger US trade deal developing in China?
- Fear Of Economic Collapse Forced China To Negotiate With Trump, Quietly Reach Out First: Reuters Report
- China’s latest stimulus measures fail to impress as investors focus on U.S. trade talks
- China’s April soybean imports hit decade-low as customs delays disrupt trade
- China’s exports top forecasts helped by global rush to beat tariffs
- U.S. stocks finish slightly lower ahead of possible weekend China trade deal
The CME Group’s FedWatch Tool projects the Fed will refuse to resume cutting the Federal Funds Rate until the conclusion of its 30 July (2025-Q2) meeting. The FedWatch Tool also forecasts the Fed will reduce U.S. interest rates just twice before the end of 2025, anticipating 0.25% cuts in the Federal Funds Rate on 17 September (2025-Q3) and 10 December (2025-Q4).
The Atlanta Fed’s GDPNow tool boosted its projection of real GDP growth in the U.S. during the current quarter of 2025-Q2 from +1.1% to +2.3%. This estimate is near the upper end of the so-called “Blue Chip consensus” range, where the overall average expected real GDP growth rate for the quarter is about 0.8%.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull and bear who are watching U.S. and Chinese trade negotiators”.
Source: https://politicalcalculations.blogspot.com/2025/05/s-500-beats-small-retreat-as-trade.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
